Achieving that goal, however, took some unconventional and sometimes difficult design choices, Affera founder and CEO Doron Harlev said.
Newton, Massachusetts–based Affera’s system diagnoses, maps and treats heart arrhythmias with ablation. It’s a process that scars heart tissue to interrupt errant signals. Affera’s system uses both radiofrequency (RF) ablation and the non-thermal pulsed-field ablation tech that has been generating buzz in medtech.
In an interview, Harlev and Rebecca Seidel, president of the Cardiac Ablation Solutions business in Medtronic’s Cardiovascular Portfolio, discussed how Affera’s devices work, the challenges to develop them and what’s next for the technology.